- Home
- INTA vs AAPG Comparison
INTA vs AAPG Comparison
Compare INTA & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTA
- AAPG
- Stock Information
- Founded
- INTA 2000
- AAPG 2009
- Country
- INTA United States
- AAPG China
- Employees
- INTA N/A
- AAPG N/A
- Industry
- INTA Computer Software: Prepackaged Software
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- INTA Technology
- AAPG Health Care
- Exchange
- INTA Nasdaq
- AAPG Nasdaq
- Market Cap
- INTA 4.3B
- AAPG 3.6B
- IPO Year
- INTA 2021
- AAPG 2025
- Fundamental
- Price
- INTA $41.64
- AAPG $37.80
- Analyst Decision
- INTA Buy
- AAPG Buy
- Analyst Count
- INTA 10
- AAPG 1
- Target Price
- INTA $61.78
- AAPG N/A
- AVG Volume (30 Days)
- INTA 795.4K
- AAPG 9.1K
- Earning Date
- INTA 08-12-2025
- AAPG 08-06-2025
- Dividend Yield
- INTA N/A
- AAPG N/A
- EPS Growth
- INTA N/A
- AAPG N/A
- EPS
- INTA N/A
- AAPG N/A
- Revenue
- INTA $483,457,000.00
- AAPG $134,352,180.00
- Revenue This Year
- INTA $18.76
- AAPG N/A
- Revenue Next Year
- INTA $14.17
- AAPG $389.09
- P/E Ratio
- INTA N/A
- AAPG N/A
- Revenue Growth
- INTA 17.70
- AAPG 341.77
- 52 Week Low
- INTA $31.08
- AAPG $16.50
- 52 Week High
- INTA $77.74
- AAPG $43.58
- Technical
- Relative Strength Index (RSI)
- INTA 23.62
- AAPG N/A
- Support Level
- INTA $42.09
- AAPG N/A
- Resistance Level
- INTA $42.92
- AAPG N/A
- Average True Range (ATR)
- INTA 1.46
- AAPG 0.00
- MACD
- INTA -0.07
- AAPG 0.00
- Stochastic Oscillator
- INTA 5.63
- AAPG 0.00
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, investment banking, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.